da Silva, P.R.; do EspÃrito Santo, R.F.; Melo, C.d.O.; Pachú Cavalcante, F.E.; Costa, T.B.; Barbosa, Y.V.; e Silva, Y.M.S.d.M.; de Sousa, N.F.; Villarreal, C.F.; de Moura, R.O.;
et al. The Compound (E)-2-Cyano-N,3-diphenylacrylamide (JMPR-01): A Potential Drug for Treatment of Inflammatory Diseases. Pharmaceutics 2022, 14, 188.
https://doi.org/10.3390/pharmaceutics14010188
AMA Style
da Silva PR, do EspÃrito Santo RF, Melo CdO, Pachú Cavalcante FE, Costa TB, Barbosa YV, e Silva YMSdM, de Sousa NF, Villarreal CF, de Moura RO,
et al. The Compound (E)-2-Cyano-N,3-diphenylacrylamide (JMPR-01): A Potential Drug for Treatment of Inflammatory Diseases. Pharmaceutics. 2022; 14(1):188.
https://doi.org/10.3390/pharmaceutics14010188
Chicago/Turabian Style
da Silva, Pablo Rayff, Renan Fernandes do EspÃrito Santo, Camila de Oliveira Melo, Fábio Emanuel Pachú Cavalcante, Thássia Borges Costa, Yasmim Vilarim Barbosa, Yvnni M. S. de Medeiros e Silva, Natália Ferreira de Sousa, Cristiane Flora Villarreal, Ricardo OlÃmpio de Moura,
and et al. 2022. "The Compound (E)-2-Cyano-N,3-diphenylacrylamide (JMPR-01): A Potential Drug for Treatment of Inflammatory Diseases" Pharmaceutics 14, no. 1: 188.
https://doi.org/10.3390/pharmaceutics14010188
APA Style
da Silva, P. R., do EspÃrito Santo, R. F., Melo, C. d. O., Pachú Cavalcante, F. E., Costa, T. B., Barbosa, Y. V., e Silva, Y. M. S. d. M., de Sousa, N. F., Villarreal, C. F., de Moura, R. O., & dos Santos, V. L.
(2022). The Compound (E)-2-Cyano-N,3-diphenylacrylamide (JMPR-01): A Potential Drug for Treatment of Inflammatory Diseases. Pharmaceutics, 14(1), 188.
https://doi.org/10.3390/pharmaceutics14010188
